🚀 VC round data is live in beta, check it out!
Dynavox Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Dynavox Group and similar public comparables like Avanos Medical, Mani Inc., Conmed, Anbio Biotechnology and more.
Dynavox Group Overview
About Dynavox Group
Dynavox Group AB is engaged in assistive technology for communication. The company's Augmentative and Alternative Communication (AAC) solutions enable people with disabilities such as cerebral palsy, ALS, and spinal cord injury to communicate with a voice of their own, develop literacy skills, and live more independently. The company is a comprehensive SaaS provider with local roots. The company operates in Europe, North America, and Other countries, with the majority of revenue from North America.
Founded
1983
HQ
Employees
874
Website
Financials (LTM)
EV
$1B
Dynavox Group Financials
Dynavox Group reported last 12-month revenue of $285M and EBITDA of $64M.
In the same LTM period, Dynavox Group generated $196M in gross profit, $64M in EBITDA, and $24M in net income.
Revenue (LTM)
Dynavox Group P&L
In the most recent fiscal year, Dynavox Group reported revenue of $273M and EBITDA of $58M.
Dynavox Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $285M | XXX | $273M | XXX | XXX | XXX |
| Gross Profit | $196M | XXX | $184M | XXX | XXX | XXX |
| Gross Margin | 69% | XXX | 67% | XXX | XXX | XXX |
| EBITDA | $64M | XXX | $58M | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 21% | XXX | XXX | XXX |
| EBIT Margin | 14% | XXX | 12% | XXX | XXX | XXX |
| Net Profit | $24M | XXX | $18M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 7% | XXX | XXX | XXX |
| Net Debt | — | — | $77M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Dynavox Group Stock Performance
Dynavox Group has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
Dynavox Group's stock price is $10.85.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | 0.3% | XXX | XXX | XXX | $0.17 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDynavox Group Valuation Multiples
Dynavox Group trades at 4.4x EV/Revenue multiple, and 19.5x EV/EBITDA.
EV / Revenue (LTM)
Dynavox Group Financial Valuation Multiples
As of April 20, 2026, Dynavox Group has market cap of $1B and EV of $1B.
Equity research analysts estimate Dynavox Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Dynavox Group has a P/E ratio of 48.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | 4.4x | XXX | 4.6x | XXX | XXX | XXX |
| EV/EBITDA | 19.5x | XXX | 21.6x | XXX | XXX | XXX |
| EV/EBIT | 31.9x | XXX | 36.9x | XXX | XXX | XXX |
| EV/Gross Profit | 6.4x | XXX | 6.8x | XXX | XXX | XXX |
| P/E | 48.2x | XXX | 62.1x | XXX | XXX | XXX |
| EV/FCF | 1106.8x | XXX | (1373.6x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Dynavox Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Dynavox Group Margins & Growth Rates
Dynavox Group's revenue in the last 12 month grew by 16%.
Dynavox Group's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Dynavox Group's rule of 40 is 41% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Dynavox Group's rule of X is 66% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Dynavox Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 16% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 21% | XXX | XXX | XXX |
| EBITDA Growth | 32% | XXX | 35% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 41% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 66% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 35% | XXX | 36% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 12% | XXX | 12% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 11% | XXX | 11% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 57% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Dynavox Group Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Dynavox Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Avanos Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Mani Inc. | XXX | XXX | XXX | XXX | XXX | XXX |
| Conmed | XXX | XXX | XXX | XXX | XXX | XXX |
| Anbio Biotechnology | XXX | XXX | XXX | XXX | XXX | XXX |
| Shanghai Haohai | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dynavox Group M&A Activity
Dynavox Group acquired XXX companies to date.
Last acquisition by Dynavox Group was on XXXXXXXX, XXXXX. Dynavox Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Dynavox Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDynavox Group Investment Activity
Dynavox Group invested in XXX companies to date.
Dynavox Group made its latest investment on XXXXXXXX, XXXXX. Dynavox Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Dynavox Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Dynavox Group
| When was Dynavox Group founded? | Dynavox Group was founded in 1983. |
| Where is Dynavox Group headquartered? | Dynavox Group is headquartered in Sweden. |
| How many employees does Dynavox Group have? | As of today, Dynavox Group has over 874 employees. |
| Who is the CEO of Dynavox Group? | Dynavox Group's CEO is Fredrik Ruben. |
| Is Dynavox Group publicly listed? | Yes, Dynavox Group is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Dynavox Group? | Dynavox Group trades under DYVOX ticker. |
| When did Dynavox Group go public? | Dynavox Group went public in 2021. |
| Who are competitors of Dynavox Group? | Dynavox Group main competitors are Avanos Medical, Mani Inc., Conmed, Anbio Biotechnology. |
| What is the current market cap of Dynavox Group? | Dynavox Group's current market cap is $1B. |
| What is the current revenue of Dynavox Group? | Dynavox Group's last 12 months revenue is $285M. |
| What is the current revenue growth of Dynavox Group? | Dynavox Group revenue growth (NTM/LTM) is 16%. |
| What is the current EV/Revenue multiple of Dynavox Group? | Current revenue multiple of Dynavox Group is 4.4x. |
| Is Dynavox Group profitable? | Yes, Dynavox Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Dynavox Group? | Dynavox Group's last 12 months EBITDA is $64M. |
| What is Dynavox Group's EBITDA margin? | Dynavox Group's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of Dynavox Group? | Current EBITDA multiple of Dynavox Group is 19.5x. |
| What is the current FCF of Dynavox Group? | Dynavox Group's last 12 months FCF is $1M. |
| What is Dynavox Group's FCF margin? | Dynavox Group's last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of Dynavox Group? | Current FCF multiple of Dynavox Group is 1106.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.